Cargando…

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study

BACKGROUND: Major depressive disorder (MDD) is associated with significant impairments in health-related quality of life (HRQoL) and everyday functioning. This cohort study investigated the long-term development of HRQoL in patients with MDD and its association with patient characteristics, includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saragoussi, Delphine, Christensen, Michael Cronquist, Hammer-Helmich, Lene, Rive, Benoît, Touya, Maëlys, Haro, Josep Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973321/ https://www.ncbi.nlm.nih.gov/pubmed/29872301 http://dx.doi.org/10.2147/NDT.S159276

Ejemplares similares

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
por: Saragoussi, Delphine, et al.
Publicado: (2017)

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
por: Hammer-Helmich, Lene, et al.
Publicado: (2018)

Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
por: Haro, Josep Maria, et al.
Publicado: (2019)

Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study
por: Haro, Josep Maria, et al.
Publicado: (2018)

Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
por: Mattingly, Gregory W., et al.
Publicado: (2022)

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder
por: Lam, Raymond W, et al.
Publicado: (2018)

Creation and validation of a linear index to measure the health state of patients with depression in automated healthcare databases
por: Touya, Maëlys, et al.
Publicado: (2019)

Results and validation of an index to measure health state of patients with depression in automated healthcare databases
por: Lamy, François-Xavier, et al.
Publicado: (2019)

Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study
por: Wang, Gang, et al.
Publicado: (2020)

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
por: Baune, Bernhard T, et al.
Publicado: (2021)

Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis
por: Kangethe, Anne, et al.
Publicado: (2021)

Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
por: Touya, Maëlys, et al.
Publicado: (2022)

Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
por: McIntyre, Roger S, et al.
Publicado: (2021)

Efficacy of vortioxetine on the physical symptoms of major depressive disorder
por: Christensen, Michael Cronquist, et al.
Publicado: (2018)

Differences in Perceptions of Major Depressive Disorder Symptoms and Treatment Priorities Between Patients and Health Care Providers Across the Acute, Post-Acute, and Remission Phases of Depression
por: Baune, Bernhard T., et al.
Publicado: (2019)

Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J
por: Sumiyoshi, Tomiki, et al.
Publicado: (2021)

Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study
por: Christensen, Michael Cronquist, et al.
Publicado: (2022)

Emotional blunting in patients with depression. Part II: relationship with functioning, well-being, and quality of life
por: Christensen, Michael Cronquist, et al.
Publicado: (2022)

Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease: Do the Perspectives of Patients and Healthcare Providers Differ?
por: Christensen, Michael Cronquist, et al.
Publicado: (2020)

Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS)
por: Dissing, Agnete Skovlund, et al.
Publicado: (2023)

Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study
por: Almeida, Susana S, et al.
Publicado: (2022)

Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study
por: Polosan, Mircea, et al.
Publicado: (2022)

A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction
por: Keefe, Richard S E, et al.
Publicado: (2018)

Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer’s disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea
por: Cumbo, Eduardo, et al.
Publicado: (2023)

The effect of vortioxetine on overall patient functioning in patients with major depressive disorder
por: Florea, Ioana, et al.
Publicado: (2017)

Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study
por: Wang, Gang, et al.
Publicado: (2022)

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
por: Novick, Diego, et al.
Publicado: (2013)

Emotional blunting in patients with depression. Part I: clinical characteristics
por: Christensen, Michael Cronquist, et al.
Publicado: (2022)

Emotional blunting in patients with depression. Part III: relationship with psychological trauma
por: Christensen, Michael Cronquist, et al.
Publicado: (2022)

Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study
por: De Filippis, Sergio, et al.
Publicado: (2022)

Emotional blunting in patients with depression. Part IV: differences between patient and physician perceptions
por: Christensen, Michael Cronquist, et al.
Publicado: (2022)

Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
por: Greene, Mallik, et al.
Publicado: (2018)

Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
por: Yan, Tingjian, et al.
Publicado: (2018)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

O8.5. SCHIZOPHRENIA AND BIPOLAR DISORDER DIAGNOSIS PATTERNS: REAL-WORLD EVIDENCE FROM US CLAIMS DATABASES
por: Greene, Mallik, et al.
Publicado: (2018)

The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study
por: Jaffe, Dena H., et al.
Publicado: (2019)

Self-reported burden of caregiver of adults with depression: a cross-sectional study in five Western European countries
por: Balkaran, B. L., et al.
Publicado: (2021)

PS80. Utilization of Baseline Patient Characteristics to Evaluate the Psychometric Properties the UCSD Performance-Based Skills Assessment (UPSA) and Determine Clinically Relevant Treatment Response in 600 Patients with Major Depressive Disorder
por: Harvey, Philip D., et al.
Publicado: (2016)

Social disparities in children’s exposure to second hand smoke at home: a repeated cross-sectional survey
por: Pisinger, Charlotta, et al.
Publicado: (2012)

Health service use among children with and without eczema, asthma, and hay fever
por: Hammer-Helmich, Lene, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3tbrpa0pli663ti16plqpg8235